Cancer deaths related to obesity have surged threefold in the U.S. since 1999, with rural and minority communities hit hardest.

A new tablet-based drug is showing great promise for both type 2 diabetes and obesity — and unlike existing GLP-1 medications, it doesn’t reduce appetite or cause muscle loss. Early studies suggest ...

Midwestern states saw the highest number of people dying from obesity-linked deaths, and it's the northeast of the country ...